Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Integrative multi-region molecular profiling of primary prostate cancer in men with synchronous lymph node metastasis.
Singhal U, Nallandhighal S, Tosoian JJ, Hu K, Pham TM, Stangl-Kremser J, Liu CJ, Karim R, Plouffe KR, Morgan TM, Cieslik M, Lucianò R, Shariat SF, Finocchio N, Dambrosio L, Doglioni C, Chinnaiyan AM, Tomlins SA, Briganti A, Palapattu GS, Udager AM, Salami SS. Singhal U, et al. Among authors: nallandhighal s. Nat Commun. 2024 May 21;15(1):4341. doi: 10.1038/s41467-024-48629-y. Nat Commun. 2024. PMID: 38773085 Free PMC article.
Role of adenosine deaminase in prostate cancer progression.
Charles C, Lloyd SM, Piyarathna DWB, Gohlke J, Rasaily U, Putluri V, Simons BW, Zaslavsky A, Nallandhighal S, Michailidis G, Palanisamy N, Navone N, Jones JA, Ittmann MM, Putluri N, Rowley DR, Salami SS, Palapattu GS, Sreekumar A. Charles C, et al. Among authors: nallandhighal s. Am J Clin Exp Urol. 2023 Dec 15;11(6):594-612. eCollection 2023. Am J Clin Exp Urol. 2023. PMID: 38148936 Free PMC article.
Analysis of the Tumor Immune Microenvironment (TIME) in Clear Cell Renal Cell Carcinoma (ccRCC) Reveals an M0 Macrophage-Enriched Subtype: An Exploration of Prognostic and Biological Characteristics of This Immune Phenotype.
Farha M, Nallandhighal S, Vince R, Cotta B, Stangl-Kremser J, Triner D, Morgan TM, Palapattu GS, Cieslik M, Vaishampayan U, Udager AM, Salami SS. Farha M, et al. Among authors: nallandhighal s. Cancers (Basel). 2023 Nov 22;15(23):5530. doi: 10.3390/cancers15235530. Cancers (Basel). 2023. PMID: 38067234 Free PMC article.
Multigene Profiling of Circulating Tumor Cells (CTCs) for Prognostic Assessment in Treatment-Naïve Metastatic Hormone-Sensitive Prostate Cancer (mHSPC).
Reichert ZR, Kasputis T, Nallandhighal S, Abusamra SM, Kasputis A, Haruray S, Wang Y, Williams S, Singhal U, Alva A, Cackowski FC, Caram MEV, Palmbos PL, Yentz SE, Smith DC, Alumkal JJ, Morgan TM. Reichert ZR, et al. Among authors: nallandhighal s. Int J Mol Sci. 2021 Dec 21;23(1):4. doi: 10.3390/ijms23010004. Int J Mol Sci. 2021. PMID: 35008431 Free PMC article.
Molecular Characterization of Clear Cell Renal Cell Carcinoma Reveals Prognostic Significance of Epithelial-mesenchymal Transition Gene Expression Signature.
Nallandhighal S, Vince R, Karim R, Groves S, Stangl-Kremser J, Russell C, Hu K, Pham T, Cani AK, Liu CJ, Zaslavsky A, Mehra R, Cieslik M, Morgan TM, Palapattu GS, Udager AM, Salami SS. Nallandhighal S, et al. Eur Urol Oncol. 2022 Feb;5(1):92-99. doi: 10.1016/j.euo.2021.10.007. Epub 2021 Nov 26. Eur Urol Oncol. 2022. PMID: 34840106
Development of a Whole-urine, Multiplexed, Next-generation RNA-sequencing Assay for Early Detection of Aggressive Prostate Cancer.
Cani AK, Hu K, Liu CJ, Siddiqui J, Zheng Y, Han S, Nallandhighal S, Hovelson DH, Xiao L, Pham T, Eyrich NW, Zheng H, Vince R Jr, Tosoian JJ, Palapattu GS, Morgan TM, Wei JT, Udager AM, Chinnaiyan AM, Tomlins SA, Salami SS. Cani AK, et al. Among authors: nallandhighal s. Eur Urol Oncol. 2022 Aug;5(4):430-439. doi: 10.1016/j.euo.2021.03.002. Epub 2021 Mar 31. Eur Urol Oncol. 2022. PMID: 33812851 Free PMC article.
Tumor size and genomic risk in localized prostate cancer.
Gaffney C, Liu D, Cooley V, Ma X, Angulo C, Robinson B, Khani F, Cai P, Salami S, Nallandhighal S, Shoag J, Barbieri C. Gaffney C, et al. Among authors: nallandhighal s. Urol Oncol. 2021 Jul;39(7):434.e17-434.e22. doi: 10.1016/j.urolonc.2021.01.020. Epub 2021 Feb 6. Urol Oncol. 2021. PMID: 33563537
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors.
Zaslavsky AB, Adams MP, Cao X, Maj T, Choi JE, Stangl-Kremser J, Patel S, Putelo A, Lee SK, Nallandhighal S, Kasputis A, Alva A, Lew M, Qin A, Mehra R, Morgan TM, Salami SS, Reichert Z, Udager A, Zou W, Palapattu GS. Zaslavsky AB, et al. Among authors: nallandhighal s. Sci Rep. 2020 Nov 9;10(1):19296. doi: 10.1038/s41598-020-76351-4. Sci Rep. 2020. PMID: 33168847 Free PMC article.
15 results